OneCapsule is a next-generation oral vaccine platform redefining how the world prevents diarrheal and enteric infections.

Our patented capsule technology is designed to provide dual protection — offering both immediate defense and lasting immunity — in a single, easy-to-take oral dose. Unlike conventional vaccines, OneCapsule is being developed to be heat-stable, antibiotic-free, and needle-free, making it accessible for use anywhere in the world.

The platform has the potential to address multiple markets:

Travel Health & Defense – protecting 200M+ international travelers annually, as well as deployed personnel and NGOs.

Global Child Health – helping reduce the more than 500,000 preventable child deaths from diarrheal disease each year in low-income countries.

By combining innovative science with practical design, OneCapsule is positioned to become the first broad-spectrum, heat-stable oral prophylaxis for diarrheal disease — with applications that extend from high-income markets to global health.

Investigational product under development; not approved for clinical use.

OneCapsule

Org chart

Teams

Offices

OneCapsule

Org chart

Teams

Offices

Related companies